Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

960
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
960
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

590
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
590
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

4.3K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

903
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
903
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paediatric bronchiectasis phenotypes and their association with clinical outcomes: development and validation in two prospective clinical cohorts.

Thorax·2026
Same author

Neutrophil-related gene expression profile is associated with future paediatric bronchiectasis exacerbations.

Journal of molecular medicine (Berlin, Germany)·2026
Same author

Improving asthma control assessment and outcomes in children with asthma using an artificial intelligence digital tool: a prospective multicentre cohort study.

ERJ open research·2026
Same author

Development of a paediatric severity score to predict outcomes of radiographic-confirmed community-acquired pneumonia in hospitalised children in Sabah, Malaysia.

Archives of disease in childhood·2026
Same author

Short and long-term effects of a play-based therapeutic exercise programme in children with non-cystic fibrosis bronchiectasis: A randomised controlled trial.

Journal of science and medicine in sport·2026
Same author

Improving the management and outcomes of preschool wheeze: protocol of a prospective multicentre cohort study.

BMJ open respiratory research·2026
Same journal

Improving the follow-up of children and adults with prematurity-associated lung disease.

Expert review of respiratory medicine·2026
Same journal

A profile on inhaled treprostinil for pulmonary hypertension.

Expert review of respiratory medicine·2026
Same journal

Effect of depemokimab on asthma control and clinical outcomes: a systematic review and meta-analysis of randomized controlled trials.

Expert review of respiratory medicine·2026
Same journal

MicroRNAs in exhaled breath condensate and plasma for diagnosis of asbestos-related interstitial lung diseases.

Expert review of respiratory medicine·2026
Same journal

Bovhyaluronidase azoximer for long-term pulmonary sequelae of COVID19: a multicenter, randomized, double-blind, placebo-controlled study.

Expert review of respiratory medicine·2026
Same journal

Role of myositis autoantibodies in diagnosing interstitial lung disease in patients with idiopathic inflammatory myopathies: a retrospective analysis.

Expert review of respiratory medicine·2026
See all related articles

Related Experiment Video

Updated: Mar 1, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K

An update on pediatric bronchiectasis.

Danielle F Wurzel1,2, Anne B Chang3,4

  • 1a The Royal Children's Hospital , Parkville , Australia.

Expert Review of Respiratory Medicine
|May 26, 2017
PubMed
Summary
This summary is machine-generated.

Pediatric bronchiectasis, a growing respiratory concern, lacks sufficient research and targeted treatments. Future strategies must focus on early life factors to improve long-term outcomes.

Keywords:
Bronchiectasischildrencoughtreatment

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.7K
P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

11.9K

Related Experiment Videos

Last Updated: Mar 1, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K
Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.7K
P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

11.9K

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Research

Background:

  • Non-cystic fibrosis (CF) bronchiectasis is increasingly recognized globally, causing significant respiratory illness, mortality, and healthcare use.
  • Early origins of pediatric bronchiectasis are a critical research priority due to limited current treatments.
  • Existing pediatric treatments include antimicrobials, airway clearance, and vaccination, with new anti-inflammatory drugs in development.

Purpose of the Study:

  • To review current management strategies for pediatric bronchiectasis.
  • To discuss existing and emerging therapeutics, including non-pharmacological interventions.
  • To highlight the need for increased research into childhood bronchiectasis treatments.

Main Methods:

  • Review of current adult and pediatric data on bronchiectasis treatments.
  • Discussion of emerging therapeutic agents.
  • Analysis of preventative and surveillance strategies.

Main Results:

  • Current research on pediatric bronchiectasis treatments is notably scarce compared to cystic fibrosis.
  • Interventions for pediatric bronchiectasis are limited, underscoring a gap in evidence-based care.
  • Emerging therapeutics show promise but require further investigation.

Conclusions:

  • Tailored interventions are crucial for halting pediatric bronchiectasis at its onset.
  • Understanding early-life respiratory infections and immune interactions is key to developing preventative strategies.
  • Improved research and targeted therapies are imperative to enhance long-term outcomes for children with bronchiectasis.